Galera plans Form 15 filing to end SEC registration, suspend Exchange Act reporting after merger
Reuters2026/08/04 10:13- Galera shares expected to stop quoting on the OTCQB following completion of its merger into Obsidian Therapeutics on Aug. 3, 2026.
- Form 15 filing planned after the close on Aug. 3 to terminate Section 12(g) registration, suspending Exchange Act reporting immediately.
- Deregistration to become effective 90 days later unless the SEC acts sooner.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs evaluates Apple's foldable iPhone: Pricing is “affordable,” with shipments this year reaching up to 35 million units
A Goldman Sachs report indicates that iPhone Duo, with its "thinnest ever" design and "affordable" pricing, is expected to open up the mass market. The forecast for 2026 remains at 14 to 35 million units shipped. The new product's upgrades in hinges, cooling, and camera technologies will benefit the supply chain in Greater China, including Foxconn.
Nissan reorganizes Japan manufacturing footprint, shifts vehicle production among plants
Sekisui Chemical housing order value falls 4% in August, units down 6%
Crypto prices
More
